A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Clinical trial NCT05009069 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05009069
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2023-11-21
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.